InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (24 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
24
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the complete record of transactions filed by Yale Catriona, Chief Development Officer. Insider active across 1 company, notably Akero Therapeutics, Inc.. Aggregated, 52 disclosures have been logged. Breakdown: 0 buy · 24 sells. Total volume traded: €3.4m. History available since 15 July 2021. The latest transaction was filed on 4 November 2025 (Levée d'options). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Yale Catriona
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations52 total
27,227 sharesCommon StockSEC:0001193125-25-312100:0
47,573 sharesCommon StockSEC:0001193125-25-312100:1
3,527 shares@ US$28.351.4% of flowCommon StockSEC:0001193125-25-268032:0
659 shares@ US$43.020.4% of flowCommon StockSEC:0000950170-25-114665:0
10,000 shares@ US$19.872.9% of flowCommon StockSEC:0000950170-25-097013:0
890 shares@ US$23.8680.3% of flowCommon StockSEC:0000950170-25-093322:0
1,633 shares@ US$54.841.4% of flowCommon StockSEC:0000950170-25-088636:0
10,000 shares@ US$21.103.2% of flowCommon StockSEC:0000950170-25-088207:0
2,803 shares@ US$53.9962.4% of flowCommon StockSEC:0000950170-25-085671:0
10,000 shares@ US$21.103.1% of flowCommon StockSEC:0000950170-25-074708:0
9,073 shares@ US$21.102.7% of flowCommon StockSEC:0000950170-25-054893:0
10,000 shares@ US$21.103.1% of flowCommon StockSEC:0000950170-25-041458:0
614 shares@ US$44.880.4% of flowCommon StockSEC:0000950170-25-039736:0
10,000 shares@ US$21.103.3% of flowCommon StockSEC:0000950170-25-024996:0
16,849 shares@ US$0.6150.2% of flowCommon StockSEC:0000950170-25-011445:0
49,074 shares@ US$21.1016.0% of flowCommon StockSEC:0000950170-25-011444:0
24,300 shares0Common StockSEC:0000950170-24-138146:0
2,810 shares@ US$30.791.3% of flowCommon StockSEC:0000950170-24-136019:0
9,061 shares@ US$21.102.9% of flowCommon StockSEC:0000950170-24-128994:0
8,761 shares@ US$27.6943.7% of flowCommon StockSEC:0000950170-24-128994:1
300 shares@ US$28.8230.1% of flowCommon StockSEC:0000950170-24-128994:2
10,000 shares@ US$0.6150.1% of flowCommon StockSEC:0000950170-24-124230:0
4,515 shares@ US$21.101.4% of flowCommon StockSEC:0000950170-24-120231:0
14,825 shares@ US$0.6150.1% of flowCommon StockSEC:0000950170-24-115138:0
5,500 shares@ US$0.6150.0% of flowCommon StockSEC:0000950170-24-108837:0
25 of 52 declarations
About Yale Catriona
Yale Catriona is Chief Development Officer at Akero Therapeutics, Inc. She has 52 filings in total, and across the sampled recent filings, sells total 3418954 EUR between 2021-07-19 and 2025-12-09.
